Internalized by tumor cells, bAC NPs could act synergistically with PDT to destroy nearby tumor cells and cause acute hypoxia, allowing the nanoparticles to cleave azobenzene junctions stimulated by azoreductase, which in turn accelerates the release of CPT. This evidence concerns the gene NQO1 and neoplasm.